Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT for Treatment of ADHD in Patients 6 Years and Older
January 27, 2016 at 19:59 PM EST
Neos Therapeutics, Inc. (Nasdaq: NEOS) today announced that the U.S. Food and Drug Administration (FDA) approved Adzenys XR-ODT™ for the ...